Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2011-12-01Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in miceTan, Y; Sun, LQ; Kamal, MA; Wang, X; Seale, JP; Qu, X
2016-08-26Characterisation of Bone Beneficial Components from Australian Wallaby Bone.Lao, W; Jin, X; Tan, Y; Xiao, L; Padula, MP; Bishop, DP; Reedy, B; Ong, M; Kamal, MA; Qu, X
2009-12-01Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer diseaseKamal, MA; Tan, Y; Seale, JP; Qu, X
2017-01-01Inhibition of butyrylcholinesterase with fluorobenzylcymserine, an experimental Alzheimer’s drug candidate: Validation of enzoinformatics results by classical and innovative enzyme kinetic analysesKamal, MA; Shakil, S; Nawaz, MS; Yu, QS; Tweedie, D; Tan, Y; Qu, X; Greig, NH
2011-04-01Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndromeTan, Y; Kamal, MA; Wang, ZZ; Xiao, W; Seale, JP; Qu, X
2020-12-09Antrodia cinnamomea Inhibits Growth and Migration of Lung Cancer Cells through Regulating p53-Bcl2 and MMPs Pathways.Tan, Y; Johnson, M; Zhou, J; Zhao, Y; Kamal, MA; Qu, X
2013-01Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats.Tan, Y; Lao, W; Xiao, L; Wang, Z; Xiao, W; Kamal, MA; Seale, JP; Qu, X
2008-06-01Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysisKamal, MA; Qu, X; Yu, QS; Tweedie, D; Holloway, HW; Li, Y; Tan, Y; Greig, NH
Results 1-8 of 8 (Search time: 0.026 seconds).
  • previous
  • 1
  • next